DAILY RESEARCH NEWS (BLOG)

The U.S. Food and Drug Administration (FDA) approved Rituxan Hycela for subcutaneous injection. According to the company, this new treatment...

Lion Biotechnologies, Inc.’s LN-144 achieved a 29 percent objective response rate in a study of patients with advanced metastatic melanoma. The...